MedTrace Logo

Calcinosis in a Single-Center Scleroderma Population

NCT02062125 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2024-03-21

No results posted yet for this study

Summary

This is a 10 year study of scleroderma patients with calcinosis 1) to better understand how common and if there are any risk factors for having calcinosis

2\) to identify common complications associated with scleroderma-related calcinosis.

.

Conditions

  • Scleroderma
  • Calcinosis

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2024-03-15
Completion
2024-03-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062125 on ClinicalTrials.gov